Masimo International Sarl

Masimo is a global medical technology company that develops and produces a wide array of industry-leading monitoring technologies, including innovative measurements, sensors, patient monitors, and consumer solutions.

Their mission is to improve patient outcomes, reduce the cost of care, and take noninvasive monitoring to new sites and applications.  Masimo’s breakthrough SET® pulse oximetry and rainbow® Pulse CO-Oximetry measurements, introduced in 1995 and 2005 respectively, allow accurate, reliable noninvasive and continuous monitoring in challenging conditions like motion and low perfusion, and of blood constituents that previously could only be measured invasively, like total hemoglobin (SpHb®).

Powered by the Masimo Hospital Automation™ platform, Masimo connectivity, automation, and telehealth solutions continue to improve and automate care delivery both in the hospital and the home.

From the Root® connectivity hub and Patient SafetyNet™ remote monitoring and clinician notification system, to home-based Masimo SafetyNet® for tetherless remote patient management and the newly announced W1™ watch, Masimo continues to advance the forefront of care during the pandemic and beyond, while at the same time expanding into additional measurement areas such as SedLine® and O3® brain monitoring,  NomoLine® capnography, softFlow™ nasal high-flow therapy, and Bridge™ opioid symptom withdrawal therapy.